Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price3.44 USD
Fair value5.93
Ethical score94.7/100
RatingOPPORTUNITY
Our investment reviews on this name
2026-09-21Read Markdown3.37+2.1% to today
2026-08-21Read Distribution3.57-3.6% to today ✓
2026-07-02Read Markup5.18-33.6% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
AmpliTech Group, Inc. holds its Markdown at $3.44. The statistical read favours the sellers, held for 9 days.
As held on the ledger · 2026-09-24
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 9 days
Price at the screen
$3.44
Valuation
N/A trailing · 6.37 forward price to earnings
Values screen
PASS· score 94.7
Beta
-0.22
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
6.41%
Below 33%
Interest-bearing debt is just 6.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
7.64%
Below 33%
Cash held in interest-bearing accounts and securities is 7.6% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
AmpliTech Group, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-03. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 72% discount to our $5.93 fair value, weak competitive moat.
Fair value range in USD, drawn from the 2026-09-24 screen. The gold marker is the market price at the same screen. A 72.4% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-24 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Microwave parts powering unseen connections worldwide
Every time a satellite beams data or a defence radar locks onto a signal, the hardware needs clean amplification without extra noise. AmpliTech builds those niche microwave components for customers the giants often ignore. This is a business growing revenue at 49% a year and trading at 12.3 times forward earnings, just below our $7 fair value with a slim margin of safety.
Why it stands out. The ethical screen clears the company, and the single analyst target sits at the same $7 level, pointing to a compact operator with genuine top-line momentum in a specialised corner of communications equipment.
Yet profit margins sit at minus 25%, return on equity is minus 16%, and the moat remains weak. Currency swings, customer concentration and thin analyst coverage add real volatility around any recovery in earnings. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AMPG trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Markdown$3.44+2.1%Entry 8
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.1% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
2026-09-21Markdown · changed$3.37-5.6%Entry 7
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 46.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
2026-07-21Markup$6.64+28.2%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 28.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
2026-07-18Markup$5.18+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
2026-07-17Markup$5.18+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (95). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.
2026-07-03Markup$5.18+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (95). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$5.18Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with near-perfect ethical score (95). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
